Correlation Between Dupont De and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dupont De and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dupont De and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dupont De Nemours and Larimar Therapeutics, you can compare the effects of market volatilities on Dupont De and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dupont De with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dupont De and Larimar Therapeutics.
Diversification Opportunities for Dupont De and Larimar Therapeutics
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dupont and Larimar is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Dupont De Nemours and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Dupont De is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dupont De Nemours are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Dupont De i.e., Dupont De and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Dupont De and Larimar Therapeutics
Allowing for the 90-day total investment horizon Dupont De Nemours is expected to generate 0.25 times more return on investment than Larimar Therapeutics. However, Dupont De Nemours is 4.01 times less risky than Larimar Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 8,026 in Dupont De Nemours on August 31, 2024 and sell it today you would earn a total of 364.00 from holding Dupont De Nemours or generate 4.54% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Dupont De Nemours vs. Larimar Therapeutics
Performance |
Timeline |
Dupont De Nemours |
Larimar Therapeutics |
Dupont De and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dupont De and Larimar Therapeutics
The main advantage of trading using opposite Dupont De and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dupont De position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.Dupont De vs. Eastman Chemical | Dupont De vs. Linde plc Ordinary | Dupont De vs. Ecolab Inc | Dupont De vs. Sherwin Williams Co |
Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Stocks Directory Find actively traded stocks across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |